AEM vs NWGL

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

NWGL exhibits a fragile financial profile with a Piotroski F-Score of 4/9, placing it in the 'stable' but lower-tier health category. The company is suffering from severe operational distress, evidenced by a -40.86% profit margin and a catastrophic -31.40% year-over-year revenue contraction. With a 52-week price collapse of approximately 85% and a technical trend score of 0/100, the stock is in a clear long-term bearish trajectory. The lack of positive earnings renders traditional valuation models like the Graham Number inapplicable, leaving the stock trading at a premium to its book value despite declining fundamentals.